136 related articles for article (PubMed ID: 1696942)
21. Immunohistochemical staining techniques of intraocular tumors.
Kochavi O; Munichor M; Lichtig C; Meyer E
Ann Ophthalmol; 1992 Sep; 24(9):347-51. PubMed ID: 1471823
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
23. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
24. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
25. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
26. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
27. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
29. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
[TBL] [Abstract][Full Text] [Related]
30. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
31. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
Mäkitie T; Carpén O; Vaheri A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta in uveal melanoma.
Esser P; Grisanti S; Bartz-Schmidt K
Microsc Res Tech; 2001 Feb; 52(4):396-400. PubMed ID: 11170298
[TBL] [Abstract][Full Text] [Related]
33. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
34. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
[TBL] [Abstract][Full Text] [Related]
35. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
[TBL] [Abstract][Full Text] [Related]
36. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
37. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
38. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
[TBL] [Abstract][Full Text] [Related]
40. Isolated ovarian metastasis from a spindle cell malignant melanoma of the choroid 14 years after enucleation: prognostic implication of the keratin immunophenotype.
Santeusanio G; Ventura L; Mauriello A; Carosi M; Spagnoli LG; Maturo P; Terranova L; Romanini C
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):329-33. PubMed ID: 11127926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]